SK Bioscience licenses CDC technology for rotavirus vaccine

SK Bioscience said Tuesday it has signed a licensing agreement with the US Centers for Disease Control and Prevention to develop an injectable rotavirus vaccine, expanding its pipeline of vaccines aimed at children in low- and middle-income countries. Under the agreement, SK Bioscience will acquire rights to the CDC's injectable inactivated rotavirus vaccine technology and localize the platform while establishing a manufacturing process designed to improve efficacy and lower production costs. Th

By The Korea Herald